Log in
Enquire now
‌

US Patent 8389531 Process for erlotinib hydrochloride

Patent 8389531 was granted and assigned to Hetero Drugs Limited on March, 2013 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Currently, there are no issues on this topic.

Find more entities like US Patent 8389531 Process for erlotinib hydrochloride

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.